| Literature DB >> 35298903 |
Ila Mishra1, Wei Rose Xie1, Juan C Bournat2, Yang He3, Chunmei Wang3, Elizabeth Sabath Silva1, Hailan Liu3, Zhiqiang Ku4, Yinghua Chen5, Bernadette O Erokwu6, Peilin Jia7, Zhongming Zhao7, Zhiqiang An4, Chris A Flask6, Yanlin He8, Yong Xu3, Atul R Chopra9.
Abstract
Asprosin is a fasting-induced glucogenic and centrally acting orexigenic hormone. The olfactory receptor Olfr734 is known to be the hepatic receptor for asprosin that mediates its effects on glucose production, but the receptor for asprosin's orexigenic function has been unclear. Here, we have identified protein tyrosine phosphatase receptor δ (Ptprd) as the orexigenic receptor for asprosin. Asprosin functions as a high-affinity Ptprd ligand in hypothalamic AgRP neurons, regulating the activity of this circuit in a cell-autonomous manner. Genetic ablation of Ptprd results in a strong loss of appetite, leanness, and an inability to respond to the orexigenic effects of asprosin. Ablation of Ptprd specifically in AgRP neurons causes resistance to diet-induced obesity. Introduction of the soluble Ptprd ligand-binding domain in the circulation of mice suppresses appetite and blood glucose levels by sequestering plasma asprosin. Identification of Ptprd as the orexigenic asprosin receptor creates a new avenue for the development of anti-obesity therapeutics.Entities:
Keywords: AgRP; Ptprd; appetite; asprosin; hypothalamus; metabolism; obesity; receptor
Mesh:
Substances:
Year: 2022 PMID: 35298903 PMCID: PMC8986618 DOI: 10.1016/j.cmet.2022.02.012
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 31.373